Abstract
Design: A bibliographic search was conducted and the authors selected studies evaluating individual consumption of chlorinated drinking water and bladder cancer. The authors extracted from each study risk estimates for intermediate and long term (>40 years) consumption of chlorinated water, stratified by sex when possible, and performed meta-analysis for the two exposure levels. A meta-analysis was also performed of the dose-response regression slopes.
Setting: Populations in Europe and North America.
Participants: Those included in six case-control studies (6084 incident bladder cancer cases, 10 816 controls) and two cohort studies (124 incident bladder cancer cases) fulfilling the inclusion criteria.
Main results: Ever consumption of chlorinated drinking water was associated with an increased risk of bladder cancer in men (combined OR=1.4, 95%CI 1.1 to 1.9) and women (combined OR=1.2, 95%CI 0.7 to 1.8). The combined OR for mid-term exposure in both genders was 1.1 (95% CI 1.0 to 1.2) and for long term exposure was 1.4 (95%CI 1.2 to 1.7). The combined estimate of the slope for a linear increase in risk was 1.13 (95% CI 1.08 to 1.20) for 20 years and 1.27 (95% CI 1.15 to 1.43) for 40 years of exposure in both sexes.
Conclusions: This meta-analysis of the best available epidemiological evidence indicates that long term consumption of chlorinated drinking water is associated with bladder cancer, particularly in men. The observed relative risk is only moderately high, but the population attributable risk could be important as the vast majority of the population of industrialised countries is potentially exposed to chlorination byproducts for long time periods.
Full Text
The Full Text of this article is available as a PDF (247.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Backer L. C., Ashley D. L., Bonin M. A., Cardinali F. L., Kieszak S. M., Wooten J. V. Household exposures to drinking water disinfection by-products: whole blood trihalomethane levels. J Expo Anal Environ Epidemiol. 2000 Jul-Aug;10(4):321–326. doi: 10.1038/sj.jea.7500098. [DOI] [PubMed] [Google Scholar]
- Begg C. B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 Dec;50(4):1088–1101. [PubMed] [Google Scholar]
- Berlin J. A., Longnecker M. P., Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology. 1993 May;4(3):218–228. doi: 10.1097/00001648-199305000-00005. [DOI] [PubMed] [Google Scholar]
- Bull R. J., Sanchez I. M., Nelson M. A., Larson J. L., Lansing A. J. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology. 1990 Sep;63(3):341–359. doi: 10.1016/0300-483x(90)90195-m. [DOI] [PubMed] [Google Scholar]
- Cantor K. P. Drinking water and cancer. Cancer Causes Control. 1997 May;8(3):292–308. doi: 10.1023/a:1018444902486. [DOI] [PubMed] [Google Scholar]
- Cantor K. P., Hoover R., Hartge P., Mason T. J., Silverman D. T., Altman R., Austin D. F., Child M. A., Key C. R., Marrett L. D. Bladder cancer, drinking water source, and tap water consumption: a case-control study. J Natl Cancer Inst. 1987 Dec;79(6):1269–1279. [PubMed] [Google Scholar]
- Cantor K. P., Lynch C. F., Hildesheim M. E., Dosemeci M., Lubin J., Alavanja M., Craun G. Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology. 1998 Jan;9(1):21–28. [PubMed] [Google Scholar]
- DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
- Doyle T. J., Zheng W., Cerhan J. R., Hong C. P., Sellers T. A., Kushi L. H., Folsom A. R. The association of drinking water source and chlorination by-products with cancer incidence among postmenopausal women in Iowa: a prospective cohort study. Am J Public Health. 1997 Jul;87(7):1168–1176. doi: 10.2105/ajph.87.7.1168. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629–634. doi: 10.1136/bmj.315.7109.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Freedman D. M., Cantor K. P., Lee N. L., Chen L. S., Lei H. H., Ruhl C. E., Wang S. S. Bladder cancer and drinking water: a population-based case-control study in Washington County, Maryland (United States). Cancer Causes Control. 1997 Sep;8(5):738–744. doi: 10.1023/a:1018431421567. [DOI] [PubMed] [Google Scholar]
- Galbraith R. F. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988 Aug;7(8):889–894. doi: 10.1002/sim.4780070807. [DOI] [PubMed] [Google Scholar]
- Gottlieb M. S., Carr J. K. Case-control cancer mortality study and chlorination of drinking water in Louisiana. Environ Health Perspect. 1982 Dec;46:169–177. doi: 10.1289/ehp.8246169. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greenland S., Longnecker M. P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992 Jun 1;135(11):1301–1309. doi: 10.1093/oxfordjournals.aje.a116237. [DOI] [PubMed] [Google Scholar]
- Jo W. K., Weisel C. P., Lioy P. J. Chloroform exposure and the health risk associated with multiple uses of chlorinated tap water. Risk Anal. 1990 Dec;10(4):581–585. doi: 10.1111/j.1539-6924.1990.tb00542.x. [DOI] [PubMed] [Google Scholar]
- Jo W. K., Weisel C. P., Lioy P. J. Routes of chloroform exposure and body burden from showering with chlorinated tap water. Risk Anal. 1990 Dec;10(4):575–580. doi: 10.1111/j.1539-6924.1990.tb00541.x. [DOI] [PubMed] [Google Scholar]
- King W. D., Marrett L. D. Case-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada). Cancer Causes Control. 1996 Nov;7(6):596–604. doi: 10.1007/BF00051702. [DOI] [PubMed] [Google Scholar]
- Koivusalo M., Hakulinen T., Vartiainen T., Pukkala E., Jaakkola J. J., Tuomisto J. Drinking water mutagenicity and urinary tract cancers: a population-based case-control study in Finland. Am J Epidemiol. 1998 Oct 1;148(7):704–712. doi: 10.1093/aje/148.7.704. [DOI] [PubMed] [Google Scholar]
- Komulainen H., Kosma V. M., Vaittinen S. L., Vartiainen T., Kaliste-Korhonen E., Lötjönen S., Tuominen R. K., Tuomisto J. Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat. J Natl Cancer Inst. 1997 Jun 18;89(12):848–856. doi: 10.1093/jnci/89.12.848. [DOI] [PubMed] [Google Scholar]
- Lau J., Ioannidis J. P., Schmid C. H. Summing up evidence: one answer is not always enough. Lancet. 1998 Jan 10;351(9096):123–127. doi: 10.1016/S0140-6736(97)08468-7. [DOI] [PubMed] [Google Scholar]
- Lynch C. F., Woolson R. F., O'Gorman T., Cantor K. P. Chlorinated drinking water and bladder cancer: effect of misclassification on risk estimates. Arch Environ Health. 1989 Jul-Aug;44(4):252–259. doi: 10.1080/00039896.1989.9935891. [DOI] [PubMed] [Google Scholar]
- Matsumura H., Watanabe M., Matsumoto K., Ohta T. 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) induces gene mutations and inhibits metabolic cooperation in cultured Chinese hamster cells. J Toxicol Environ Health. 1994 Sep;43(1):65–72. doi: 10.1080/15287399409531904. [DOI] [PubMed] [Google Scholar]
- McGeehin M. A., Reif J. S., Becher J. C., Mangione E. J. Case-control study of bladder cancer and water disinfection methods in Colorado. Am J Epidemiol. 1993 Oct 1;138(7):492–501. doi: 10.1093/oxfordjournals.aje.a116883. [DOI] [PubMed] [Google Scholar]
- Moher D., Cook D. J., Eastwood S., Olkin I., Rennie D., Stroup D. F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999 Nov 27;354(9193):1896–1900. doi: 10.1016/s0140-6736(99)04149-5. [DOI] [PubMed] [Google Scholar]
- Morris R. D., Audet A. M., Angelillo I. F., Chalmers T. C., Mosteller F. Chlorination, chlorination by-products, and cancer: a meta-analysis. Am J Public Health. 1992 Jul;82(7):955–963. doi: 10.2105/ajph.82.7.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nieuwenhuijsen M. J., Toledano M. B., Eaton N. E., Fawell J., Elliott P. Chlorination disinfection byproducts in water and their association with adverse reproductive outcomes: a review. Occup Environ Med. 2000 Feb;57(2):73–85. doi: 10.1136/oem.57.2.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schwartz J., Levin R., Hodge K. Drinking water turbidity and pediatric hospital use for gastrointestinal illness in Philadelphia. Epidemiology. 1997 Nov;8(6):615–620. doi: 10.1097/00001648-199710000-00001. [DOI] [PubMed] [Google Scholar]
- Vena J. E., Graham S., Freudenheim J., Marshall J., Zielezny M., Swanson M., Sufrin G. Drinking water, fluid intake, and bladder cancer in western New York. Arch Environ Health. 1993 May-Jun;48(3):191–198. doi: 10.1080/00039896.1993.9940820. [DOI] [PubMed] [Google Scholar]
- Villanueva C. M., Kogevinas M., Grimalt J. O. Cloración del agua potable y efectos sobre la salud: revisión de estudios epidemiológicos. Med Clin (Barc) 2001 Jun 9;117(1):27–35. doi: 10.1016/s0025-7753(01)72000-3. [DOI] [PubMed] [Google Scholar]
- Wilkins J. R., 3rd, Comstock G. W. Source of drinking water at home and site-specific cancer incidence in Washington County, Maryland. Am J Epidemiol. 1981 Aug;114(2):178–190. doi: 10.1093/oxfordjournals.aje.a113181. [DOI] [PubMed] [Google Scholar]
- Zierler S., Danley R. A., Feingold L. Type of disinfectant in drinking water and patterns of mortality in Massachusetts. Environ Health Perspect. 1986 Nov;69:275–279. doi: 10.1289/ehp.8669275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zierler S., Feingold L., Danley R. A., Craun G. Bladder cancer in Massachusetts related to chlorinated and chloraminated drinking water: a case-control study. Arch Environ Health. 1988 Mar-Apr;43(2):195–200. doi: 10.1080/00039896.1988.9935853. [DOI] [PubMed] [Google Scholar]